The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices today voted unanimously to recommend a single COVID-19 vaccine booster dose at least six months after completing an initial mRNA COVID-19 vaccine series, in the same risk groups for whom CDC recommended a Pfizer booster dose. These risk groups include people age 65 and older and residents in long-term care settings; people aged 50-64 with underlying medical conditions; people aged 18-49 with underlying medical conditions, based on their individual benefit and risks; and people aged 18-64 who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting, based on their individual benefits and risks. 

In addition, ACIP voted unanimously to recommend a single COVID-19 vaccine booster dose for adults at least two months after receiving an initial Johnson & Johnson COVID-19 vaccine dose. 

CDC’s director next will consider the ACIP recommendations.
 

Related News Articles

Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…
Headline
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23…